Abstract Background: Guidelines and protocols assist in the clinical management of patients, helping to utilise available resources efficiently, however, there is limited documented guidance on surveillance of patients following open arterial surgery. The frequency of clinical follow up, Doppler ultrasound measurements and radiological imaging should all be justified. Here we review the available literature to offer an evidenced based approach to postoperative care. Method: An electronic search was made of Medline and Embase databases through September 2009 revealing over 2300 studies in the initial searches. Following title and abstract screening, the relevant medical literature concerning post-operative surveillance of open vascular procedures was reviewed (300 papers). 42 papers were included in this review. Surveillance recommendations were constructed from the evidence presented. Results and conclusion: Detailed anatomical imaging is available for the technical assessment in the majority of patients' postoperative management; however there is little Level 1 evidence to guide modality or timing. Grades B and C recommendations form the majority of surveillance recommendations. Clinical review remains the mainstay of surveillance following open peripheral arterial surgery. Duplex scanning is the imaging modality of choice when indicated in most instances. Minimal data exists to quantify quality of life or intervention efficacy. ª
Introduction
Vascular surgery commonly involves complex operations on patients with significant anaesthetic risks. Such operations are often designed with the fundamental ideal of improving blood flow. Technical operative success and graft patency have become the targets of many interventions. This requires measurement and assessment of the grafts e To access continuing medical education questions on this paper, please go to www.vasculareducation.com and click on 'CME'surveillance, but it also allows assessment of surgical results and intervention efficacy.
Appropriate surveillance should aim to positively influence patients' quality of life, improve vascular service efficiency and assist with service rationing; with best clinical result the over-riding goal.
Previous work in pre-malignant diseases and cancer has shown that without clear information, surveillance can be depressing and confusing 1 but the impact of a reassuring review cannot be overlooked. 2 Surveillance must have a clear therapeutic benefit, especially as with improved life expectancy, revision surgery and intervention may become a more frequent occurrence.
Evidence based medicine is the process of systematically reviewing, appraising and using clinical research findings to aid delivery of optimum clinical care to patients. 3 These studies are utilized for best practice recommendations, graded as shown in Table 1 . 4 Evidence based guidelines to support post-operative surveillance programmes are conspicuous by their absence in vascular surgery. The aim of this review is provide a summary of the available literature to help guide such programmes, and highlight the need for further research where appropriate.
This review divides interventions into three sections:
Carotid and Subclavian Intervention Aorto-iliac Intervention Infra-inguinal Intervention
Method
An electronic search was made of Medline and Embase databases through to September 2009 and relevant English language medical literature concerning post-operative surveillance of open vascular procedures reviewed. Specific terms used included surveillance, follow-up, post-operative, vascular, surgery, open, and operation name which yielded over 2300 studies. Three researchers title-screened and abstract-screened the results of the keyword searches. Exclusion criteria included papers dealing solely with endovascular techniques, non-English language, studies without clear follow-up information detailing timescales and procedure. Single case reports were also excluded. 300 papers were then critically assessed in full by the three researchers, with 42 papers and their level of evidence included in the final review. Guidelines, criteria and recommendations were assessed by all four authors. The studies are summarised in Tables 2e5. The methodology Carotid intervention (Table 2) Carotid endarterectomy 7 studies concerning carotid endarterectomy were identified with a published follow-up up protocol and surveillance assessment, and one meta-analysis. A case series of 192 patients by Golledge et al. (Level 4 evidence) showed that duplex ultrasonography within 1 week of carotid endarterectomy (CEA) identifies both gross abnormalities, such as >50% residual stenosis (n Z 4), pseudoaneurysm, intraluminal thrombus as well as minor residual (25%e50%) stenosis (n Z 25) and small internal carotid artery dimensions, which are good predictors of >50% restenosis at 6 months, which was found in 21 of the 192 cases assessed. 5 The same group showed that delayed restenosis is not associated with an increased risk of ipsilateral stroke or transient ischaemic attack (TIA) (3% vs. 6%, p > 0.5), 6 and Naylor et al. have shown no benefit from either clinical or imaging follow-up for the ispilateral side. 7 Mattos et al. 8 presented a non-significant 10 year stroke-free survival rate difference of 94.4% in carotids with restenosis following CEA versus 90.6% in non-restenosed vessels (Level 4 evidence). However, a meta-analysis by Frerick et al. failed to find evidence in favour of routine surveillance, 9 and a cost utility analysis by the same group showed no benefit in terms of quality of life improvements from surveillance. 10 Naylor et al. have previously shown that after CEA the risk of ipsilateral stroke is 1.8% per annum, 7 and of contralateral stroke 1e1.4%. 11, 12 Roth et al.'s case series of 242 carotid endarterectomy cases, surveillance has shown some benefits to monitoring contralateral disease progression after CEA, with an intervention rate of 5.9% for contralateral disease, 12 CEA may influence contralateral disease progression. Ballotta et al. 13 showed 25% (148 of 599) of mild (30e49%) or moderate (50e69%) stenoses progressed by one grouping over 3 years, with moderate stenoses progressing quickest (18.5 versus 29.8 months). Ricco et al.
14 showed a rate of recurrent ipsilateral stenosis (>50%) of 3.8% at 5 years, in a series of 605 patients (573 These studies 12e14 suggest that monitoring of contralateral disease is required at yearly intervals, if asymptomatic stenosis treatment is planned, however this remains controversial in the era of statin therapy. 15 
Recommendation
No level 1, 2 or 3 evidence exists to support surveillance or to suggest surveillance prevents further symptoms.
Level 4 evidence supports carotid duplex within 1 week to predict a restenosis of >50% at 6 months (Grade C). 5 Duplex ultrasonography at one year post-operatively is appropriate if there is a residual stenosis or contralateral stenosis >50% at 1 week post-operatively (Level 4 evidence e Grade C) and asymptomatic treatment is planned. 13 If asymptomatic treatment is not planned, there is no evidence to support surveillance.
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Subclavian artery stenosis 3 studies were found discussing subclavian artery stenosis treatment surveillance.
Transposition of subclavian artery
Subclavian artery transposition patency rates range from 98% to 100%. 16, 17 A systematic review of 58 publications (n Z 511) by Cinà et al. 17 produced a 98% cumulative patency rate at 5 years. Law et al. 16 found one asymptomatic occlusion at >13 years (n Z 9) (Level 4 evidence).
Recommendation
Level 3a evidence suggests surveillance is unwarranted due to high patency rates (Grade B).
Carotid-subclavian bypass grafting
Carotid-Subclavian Bypass Grafting utilizes three types of conduit: Polytetrafluoroethylene (PTFE), Dacron and vein grafts, with differing patency rates. In contrast to infrainguinal repair, PTFE is the best conduit with a 5-year patency rate of 95.2% 16 followed by Dacron (84%) and autologous saphenous vein (64.8%). All patency failures seen in Law et al.'s series occurred between 9 and 15 months post-operatively, irrespective of conduit. 16 AbuRahma et al. 18 provided 10-year follow-up data of PTFE bypass grafting using 6 monthly clinical review and duplex ultrasound scanning with a primary patency rate of 92%, and secondary patency rate of 95%, with the first fall in patency at 3 years.
Recommendation
Surveillance is unwarranted for PTFE grafting due to excellent primary patency rates. Surveillance of Dacron and vein grafts has not been shown to improve patency rates with re-intervention driven by symptom recurrence (Level 4 evidence e Grade C).
Aorto-iliac intervention (Table 3) 15 studies and 1 consensus document were identified regarding surveillance in aorto-iliac intervention.
Aorto-iliac and aorto-bifemoral bypass
The high flow rates of aorto-iliac and aorto-bifemoral bypass grafts appear to be protective against deterioration with studies showing good primary patency rates (aortoiliac e 88.5% at 5 years 19 and aorto-bifemoral e 93% at 3 years 20 ) . However iliac disease is now more commonly treated with stents, reserving bypass surgery for more extensive disease. Thus current aorto-iliac bypasses may have a greater risk of occlusion if the disease is more extensive. There have been no studies concerning duplex or clinical surveillance of aorto-iliac or aorto-bifemoral bypass for patency or aneurysmal dilatation.
Recommendations
Level 4 evidence suggests surveillance is unnecessary due to good primary patency rates (Grade C).
Ilio-femoral bypass
Ilio-femoral bypass is a relatively rare procedure utilised in circumstances where an aorto-femoral or a femoro-femoral crossover graft is not appropriate. 21 Melliere et al. 22 reviewed 144 bypasses (over 20 years) obtaining a primary patency rate of 66% at 8 years with annual duplex surveillance. Carsten et al. 21 reported a secondary patency rate of 97.5% and 93.3% at 1 and 5 years respectively (40 patients over 9 years). 5-year primary and secondary graft patency rates of 40 procedures by Nazzal et al. 23 were 61.3% and 80.5%. Crossover ileofemoral bypass gives primary and secondary patency rates at one year of 94% and 100%, and at 5 years of 76.7% and 95% respectively. 24 Recommendations Level 4 evidence supports annual clinical review, ABPI and colour duplex imaging for Ilio-femoral bypass; clinical review and Doppler measurements for crossover ilio-femoral bypass due to falling primary patency rates (Grade C).
Axillo-femoral bypass
There is minimal literature on follow-up of axillo-femoral bypass for aorto-iliac disease. The procedure has two separate patient groups e one with occlusive disease and one with infection of a previous graft, often for aneurysmal disease. However, due to the health of patients and the length of the bypass, both are at higher risk of complication and occlusion. 25 Due to improved surgical technique and antimicrobial treatment 3 year primary and secondary patency rates of 80.2% and 87.4% have been achieved 26 with 5 year patency rates of 66%. 27 Recommendations Level 4 evidence suggests that with similar primary and secondary patency rates there is no benefit from surveillance (Grade C).
Femoro-femoral cross-over bypass
Previously, femoro-femoral bypass (FFB) cross-over grafts have obtained inferior patency rates compared to AFB techniques, 28 despite more recent studies showing a 92% 6 year cumulative patency rate. 29 The technique offers a less invasive procedure for appropriate patients (either limited disease or unfit for AFB techniques). Initial EVAR technique utilized aorto-uniiliac prosthesis, necessitating FFB. FFB for iatrogenic obstructive disease has improved patency rates compared to naturally occurring occlusive disease, although occlusion of the bypass graft is associated with significant morbidity (20% mortality and 20% amputation rate in non-infected occluded grafts). 30 The Trans-Atlantic Inter-Society Consensus II (TASC II) 31 recommendation for diffuse and long segment unilateral iliac disease is open surgery. Ricco et al. 32 produced primary and secondary patency rates of 52% and 93% at 48 months with yearly clinical review, walking distance assessment and preand post-exercise ABPI measurements (Level 2b evidence).
Stone et al. 33 performed a retrospective review of 6 monthly duplex ultrasound surveillance on patency of FFB grafts in 108 patients. Intervention was triggered when PSV reached >300 cm/s, achieving patency rates of 95% at 1 year and 88% at 5 years (Level 4 evidence).
Recent work with femoro-popliteal deep vein grafts for FFB (where prosthetic material is contra-indicated), these conduits achieve good patency rates with 6 monthly duplex surveillance (at 1, 3 and 5 years primary patency was 97%, 93% and 76%; secondary patency 100%, 95% and 90%). Infrainguinal intervention (Table 4) 14 studies and 1 book chapter were identified concerning surveillance of infrainguinal intervention.
Infrainguinal bypass grafting is a common index procedure for vascular surgeons, but is associated with significant technical difficulty. Long-term patency is the goal for all procedures but may be unnecessary in some cases, and so limb salvage rates are often utilised to more clearly delineate results.
Autologous vein 'At risk' grafts have been defined as an ABPI fall of >0.2, having a peak mean velocity (PMV) < 45 cm/s and exit velocity/start velocity (V2/V1) of > 2. 35 A systematic review of 6649 vein grafts by Golledge et al. 36 concluded the total number of deaths, occluded grafts and the number of occlusions after 30 days were significantly greater in those not undergoing surveillance. However this surveillance did not improve the limb salvage rate.
An analysis (Level 1a evidence) of Ihlberg et al.'s data 37, 38 showed clinical surveillance was better than duplex surveillance in terms of primary and secondary patency rates. 39 Patients with no flow abnormality at 6 weeks had an 82% cumulative patency and 93% limb salvage rate at 40 months with 6 monthly clinical reviews with ABPIs (Level 2b evidence). 40 A randomised controlled trial (RCT) of 156 patients showed that duplex scans every 3 months for 2 years, with an additional scan at 3 years following femoropopliteal/ crural vein bypass surgery significantly improved assisted primary cumulative and secondary patency rates at 3 years (Level 1b evidence). 41 However no benefit was found in duplex surveillance, when compared to ABPI measurements over 3 years, in terms of patency and limb salvage (Level 1b evidence), 37 or when compared to 3 monthly ABPI's over the first postoperative year (Level 1b evidence). 38 The Vein Graft Surveillance Trial RCT of 594 patients who underwent femoropopliteal or femorocrural vein bypass showed no difference in primary patency, secondary patency and most importantly, amputation rates between duplex and clinical surveillance (Level 1b evidence). 42 In a study of 106 femoropopliteal bypass grafts (vein 56, PTFE 44, Dacron 6), successful angioplasty occurred in 22% of patients undergoing duplex surveillance on 2 out of 3 intervals of 3, 6 and 12 months. A V2:V1 ratio of >4 (70% stenosis) indicated angioplasty. A significant reduction in graft occlusion rates at 1 and 3 years with duplex surveillance was shown. Graft occlusion was commoner in critical ischaemia compared to claudication. Mortality rates were similar at 2 years. 43 There is some evidence that if duplex surveillance is used it should be tailored to operative findings and patient factors. Abnormal initial duplex testing indicating moderate (PSV: 180e300 cm/s, V2:V1 ratio of 2e3.5) stenosis, nonsingle segment saphenous vein conduit, warfarin drug therapy, and redo bypass grafting are all characteristics of duplex-detected stenoses leading to intervention and may benefit from more frequent duplex surveillance. 44 Following vein graft revision, on-going clinical and duplex surveillance is recommended; as 30.9% will develop additional lesions requiring treatment (Level 4 evidence). 45 
Prosthetic graft
Lundell et al. 41 showed no benefit at one year after 3 monthly duplex scans following femoro-popliteal/crural PTFE bypass surgery (Level 1b evidence). Dunlop et al. 46 showed no benefit with 3 monthly ABPI measurements and graft Duplex after 3 years (Level 2b evidence).
Duplex performed 3 monthly for 2 years then 6 monthly of 33 prosthetic femoro-tibial bypasses had a sensitivity and specificity of 88% and 89% at predicting an abnormal graft. 47 Brumberg et al. 48 recommended early duplex to detect low flow (midgraft velocity 45 cm/s) which predicts grafts 'at risk'.
There is no evidence supporting routine duplex surveillance of prosthetic femoro-distal bypass grafts. 49 
Recommendation
Despite conflicting reports, level 1a evidence does not support the use of post-operative duplex scan surveillance (Grade A).
Clinical deterioration and a drop in ABPI of >0.2 detects failing infrainguinal vein bypasses (Level 1b e Grade A). Figure 1 Flow diagram of studies included.
Duplex at 6 weeks helps predict which grafts are likely to fail and hence may benefit from surveillance (Grade B).
Level 1b evidence does not support the use of duplex imaging compared to clinical review and ABPI measurements every 3 months in prosthetic bypass (Grade A).
Discussion
Many diseases, both malignant and non-malignant, now have guidelines for surveillance, helping to maintain good clinical care efficiently whilst maintaining the patient's quality of life. Vascular surgery should not differ and the formation of structured follow up is overdue. The 4 key aims of surveillance e improved quality of life, service efficiency, service rationing and best clinical result; are poorly served by the evidence currently available. Structured programmes with clear patient education are the goal but extensive good quality clinical research is required to reach it. Whilst some grade A recommendations can be made, there are still plenty of grade C recommendations. With endovascular advances, surveillance comparison with open surgery would enable better evaluation of both techniques. Endovascular procedures have high rates of surveillance but controlled analyses of the benefits of such programmes are rare.
A summary of recommendations is presented in Table 5 . This review is limited by the paucity of trials and the inconsistency in reporting of follow-up and surveillance. Studies that have reported long-term follow-up have necessarily provided evidence spanning different generations of medical therapeutics, and may not be appropriate in the age of statins and multiple antiplatelet agents. The improvement of angiographic and angioplasty techniques have also changed the applicability of previous studies.
The advent of high-quality duplex ultrasonography should allow standardisation of reporting criteria and subsequently improved evidence for and against surveillance and intervention.
Conclusion
There is clearly a lack of high-level evidence for surveillance in several areas of open vascular surgery. Surveillance policies should be created and grouped using the type of operation and the use of prosthetic material, as a basis for individual management plans.
Much of the current evidence investigates whether surveillance improves graft patency rates and amputation rates. Is this the appropriate measure for patients who are at high risk of morbidity from intervention to improve falling patency, which may be asymptomatic. Studies into patients' quality of life are lacking and few studies have performed a cost analysis into vascular surveillance. Serial outpatient review of frail patients requiring hospital transport that is unnecessary is a burden to both patient and hospital staff, and resource inefficient.
Further work is needed for study guidelines to replace anecdotal practice. Whilst randomised controlled trials assessing surveillance are difficult to accomplish due to the length of study required, the lack of existing evidence provides a fertile ground for improvement. As has been shown by the RCTs for infra-inguinal grafting such trials are possible and provide vital evidence for appropriate service planning and service economics. 41, 42 Multi-centre trials are likely to be required for procedures performed infrequently, which would most benefit from standardised surveillance plans.
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